The VeriDose® Core Panel targets the most relevant variants in 20 principle genes implicated in drug metabolism pathways. It provides genotype information for 68 SNPs/INDELs across 20 genes. The panel is designed to be tolerant to low quality DNA, boosting the likelihood of success with challenging samples.